Your browser doesn't support javascript.
loading
A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma.
Tian, Xiao-Peng; Ma, Shu-Yun; Young, Ken H; Ong, Choon Kiat; Liu, Yan-Hui; Li, Zhi-Hua; Zhai, Qiong-Li; Huang, Hui-Qiang; Lin, Tong-Yu; Li, Zhi-Ming; Xia, Zhong-Jun; Zhong, Li-Ye; Rao, Hui-Lan; Li, Mei; Cai, Jun; Zhang, Yu-Chen; Zhang, Fen; Su, Ning; Li, Peng-Fei; Zhu, Feng; Xu-Monette, Zijun Y; Wong, Esther Kam Yin; Ha, Jeslin Chian Hung; Khoo, Lay Poh; Ai, Le; Cheng, Run-Fen; Lim, Jing Quan; de Mel, Sanjay; Ng, Siok-Bian; Lim, Soon Thye; Cai, Qing-Qing.
Afiliação
  • Tian XP; Department of Medical Oncology and.
  • Ma SY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Young KH; Department of Medical Oncology and.
  • Ong CK; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Liu YH; Hematopathology Division, Duke University Medical Center, Duke Cancer Institute, Durham, NC.
  • Li ZH; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.
  • Zhai QL; Oncology Academic Clinical Program (ONCO ACP), Duke-National University of Singapore (NUS) Medical School, Singapore.
  • Huang HQ; Genome Institute of Singapore, Singapore.
  • Lin TY; Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Li ZM; Department of Oncology, Sun-Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Xia ZJ; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Zhong LY; Department of Medical Oncology and.
  • Rao HL; Department of Medical Oncology and.
  • Li M; Department of Medical Oncology and.
  • Cai J; Department of Hematology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Zhang YC; Department of Hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Zhang F; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Su N; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Li PF; Department of Medical Oncology and.
  • Zhu F; Department of Medical Oncology and.
  • Xu-Monette ZY; Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Wong EKY; Department of Medical Oncology and.
  • Ha JCH; Department of Medical Oncology and.
  • Khoo LP; Hematopathology Division, Duke University Medical Center, Duke Cancer Institute, Durham, NC.
  • Ai L; Hematopathology Division, Duke University Medical Center, Duke Cancer Institute, Durham, NC.
  • Cheng RF; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.
  • Lim JQ; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.
  • de Mel S; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.
  • Ng SB; Department of Oncology, Sun-Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Lim ST; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Cai QQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Blood ; 138(6): 452-463, 2021 08 12.
Article em En | MEDLINE | ID: mdl-33728448
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polimorfismo de Nucleotídeo Único / Linfoma Extranodal de Células T-NK Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polimorfismo de Nucleotídeo Único / Linfoma Extranodal de Células T-NK Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article